万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://onlinelibrary.wiley.com/journal/15372995
3、投稿网址：
http://mc.manuscriptcentral.com/transfusion
4、官网邮箱：rmkaufman@bwh.harvard.edu
bring1@bwh.harvard.edu
更多编辑邮箱如下。
5、官网电话：如下。
6、期刊刊期：月刊，一年出版12期。
2021年5月25日星期二
投稿须知【官网信息】
AUTHOR CENTER
Submission Requirements
Title Page
Required Forms
Transfusion Editorial Office
Submission by Manuscript Type
Original Research
Brief Report
Case Report
One-Page Report of New Alleles
or Antigens
Letter to the Editor
Review Article
Rapid Review
Commentary
Clinical Research Focus
How Do I...
Transfusion Medicine
Illustrated
Transfusion Clips
Welcome to TRANSFUSION, the world’s foremost journal of transfusion medicine.
In addition to blood banking and transfusion medicine topics, TRANSFUSION presents submissions on cellular and gene therapies. Acceptance of papers for publication is based on merit; equal consideration is given to papers submitted by nonmembers and members of AABB.
Manuscripts are considered for publication on the condition that they are submitted solely to TRANSFUSION. With the exception of abstracts of 500 words or fewer that are published in connection with scientific meetings, no substantial part of the paper may have been submitted for publication elsewhere.
SUBMISSION REQUIREMENTS
To submit a manuscript, you will need to create an account in Manuscript Central. For submission requirements for specific manuscript types, please see below. If your manuscript is accepted, your corresponding author will be notified by email with the request to log in to Author Services to complete a license agreement on behalf of all authors of the paper.
Submit all manuscripts online. The entire article — 1) Title Page; 2) Abstract and Key Words; 3) Main Text; 4) Acknowledgments; 5) References; 6) Figure Legends; 7) Tables; and 8) Appendices — should be saved in a single file in Word format (.doc or .docx); only electronic figures should be supplied as separate files. Be sure to number your tables and figures (Fig. 1, Fig. 2, etc.) Do not use captions on your figures (Figure Legends suffice.) Please do not use footnotes.
TITLE PAGE
All submissions must include a TITLE PAGE that contains all of the following: 1) the title of the article, which should be concise but informative and should not include abbreviations or brand names; 2) a short running headline of no more than 40 characters (including spaces) typed at the bottom of the title page and identified as such; 3) first and last names of each author but not his/her titles, degrees, positions, or academic rank. Attribution for the work should be stated separately using superscript to indicate the name of department and institution — with location — to which the work should be attributed; 4) name, email address, telephone and fax number of the corresponding author; 5) the source(s) of support in the form of grants, equipment, or drugs; 6) DOUBLE-SPACE (2.0) your Word document and include word count; 7) include the number of figures and tables, as well as the number of references.
Please do not include brand names in the title; and no registered trademark symbols throughout the manuscript.
CONFLICT OF INTEREST: Place a Conflict of Interest statement on your Title Page to include all conflicts of interest of any of the authors. If there are no conflicts, please state that fact.
Please note that manuscripts with an incomplete Title Page will be returned for revision.
REQUIRED FORMS
The Conflict of Interest and Submission Fee forms are available on your sign-on page of Manuscript Central under “Instructions & Forms.”
PROCESS AND REVIEW OF MANUSCRIPTS
All manuscripts are subject to editing for consistency of style by the editor, the publisher, or both. Authors will be sent page proofs and a query sheet by the publisher. Only important changes in data are allowed. The page proofs and answered query sheet should be returned directly to the publisher by email or fax within 24 hours of receipt to allow for accommodation of authors’ corrections and to avoid publication delay. Manuscripts generally will be published in the order that they are accepted. The review process takes about six weeks, and most manuscripts require revision before final acceptance.
Address all inquiries to:
Betsy Ring
Managing Editor
TRANSFUSION
bring1@bwh.harvard.edu
(207) 671-8233
SUBMISSION BY MANUSCRIPT TYPE
ORIGINAL RESEARCH
Research articles are not to exceed 3,500 words, excluding the Abstract, References and Figure Legends. Place the following sections on separate pages: Title Page, Abstract and Key Words, Main Text, Acknowledgments, References, Tables, Figures, and Figure Legends. Use the active voice when possible. All pages should be saved in a single file, with the exception of Figures.
ABSTRACT：250 words
WORD LIMIT：3,500
FIGURES & TABLES：8
REFERENCES：No limit
COLOR FEE：$700/image
COI：Each author must submit a COI form.
SUBMISSION FEE：The $50 fee is waived if at least one author is an AABB member.
The text of Original Research articles is divided into sections: ABSTRACT, INTRODUCTION, MATERIALS AND METHODS, RESULTS, and DISCUSSION. Long articles may need subheads within some sections to clarify content, especially in the Materials and Methods, Results, and Discussion sections.
ABSTRACT
The ABSTRACT is divided into four sections:
BACKGROUND: Summarize the question that you attempted to answer.
STUDY DESIGN AND METHODS: Summarize how you attempted to answer the question.
RESULTS: Summarize your main findings.
DISCUSSION: Summarize the implications of your main findings.
INTRODUCTION
Clearly state the purpose of the article. Summarize the rationale for the study. Give pertinent references only. Do not include data or conclusions from work being reported.
MATERIALS AND METHODS
Clearly describe your selection of observational or experimental subjects (patients or animals, including controls, and the number in each study group). Identify the methods, equipment, reagents, and procedures used in sufficient detail to allow other colleagues to reproduce the results. Publication of an original research article implies that the authors are prepared to distribute freely to academic researchers for their own use any materials (e.g., cell lines, DNA clones, antibodies) used in the experiments. Give references to established methods; provide references and brief descriptions of methods that are not well-known; describe new or substantially modified methods, include reasons for using them, and describe their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.
Human & Animal Experiments
When reporting experiments conducted on humans, indicate whether the procedures were in accordance with the standards of the committee(s) on human experimentation of the institution(s) where the experiments took place. Details that might identify patients should be avoided unless essential for scientific purposes. If identification of patients is unavoidable, their informed consent must be obtained. When reporting experiments conducted on animals, indicate whether the institution’s or the National Research Council’s guide for the care and use of laboratory animals was followed. All manuscripts dealing with recombinant DNA research must indicate the physical and biologic containment procedures practiced, in accordance with the Health Guidelines for Research Involving Recombinant DNA Molecules established by the National Institutes of Health.
Statistics
Describe statistical methods in enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Avoid sole reliance on statistical hypothesis testing, such as the use of p values, which fails to convey important quantitative information. Discuss the eligibility of experimental subjects. Give details about randomization. Describe the methods for and success of any blinding of observations. Report treatment complications. Specify the numbers of observations. Report losses to observation (such as dropouts from a clinical trial). References for study design and statistical methods should be to standard works (with pages stated) when possible, rather than to papers in which designs or methods were originally reported. Specify any general-use computer programs used.
RESULTS
Present your results in logical sequence in the text, Tables, and Figures. Each Table or Figure must be cited in numerical order within the body of the main text. More information on Tables and Figures is presented below.
DISCUSSION
Summarize your main findings. Emphasize the new and important aspects of the study and the conclusions. Do not repeat in detail the data given in the Results section. Include in the Discussion section the implications of the findings and their limitations and relate the observations to other relevant studies. Link the conclusions with the stated purpose of the study, but avoid unqualified statements and conclusions not completely supported by the data presented. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted, and clearly label them as such. Recommendations, when appropriate, may be included.
ACKNOWLEDGMENTS
Acknowledgments include one or more statements that specify:1) contributions that should be acknowledged but do not justify authorship, such as general support by a departmental chair; 2) technical help received; 3) financial and material support, specifying the nature of the support.
People who have contributed intellectually to the paper, but whose contributions do not justify authorship, may be named and their function or contribution described as, for example, ‘scientific adviser,’ ‘critical review of study proposal,’ ‘data collection,’ or ‘participation in clinical trial’. They must have given written permission to be named. Authors are responsible for obtaining this written permission.
REFERENCES
Number the references consecutively in the order in which they are first mentioned in the text. Identify references in text, Tables, and Figure Legends by Arabic numerals superscripted (after any necessary punctuation). Please include the first three listed authors, et al. in the Reference List. Try to avoid using abstracts as references; ‘unpublished observations’ and ‘personal communications’ may not be used as references, although references to written, not oral, communication may be inserted (in parentheses) in the text. Give the name of the person from whom the communication was received and the date (month and year) of the communication. References to manuscripts accepted but not yet published may be included; designate the journal name, followed by ‘in press’ (in parentheses). Information from manuscripts submitted but not yet accepted should be cited in the text as ‘unpublished observations’ or ‘submitted for publication’ (in parentheses).
References must be verified by the author(s) against the original documents. Page numbers of articles are required. Authors may be asked to provide a copy of the document if necessary for verification.
TABLES
Type each Table clearly on a separate page. Number Tables consecutively and provide a brief title for each at the top. Give each column a short or abbreviated heading, and include units, e.g. Hemoglobin (g/dL). Place explanatory information in footnotes, not in the headings. Use superscript letters in alphabetical order for linked table footnotes (a, b, c, …); asterisks are used for levels of probability.
If data from another published or unpublished source are used, the authors must obtain written permission to publish the data in the journal. Enclose a copy of the permission when submitting the manuscript and acknowledge the source fully. Some sources charge a fee to reprint information. It is the authors’ responsibility to pay any fees associated with publishing data from another source. TRANSFUSION does not pay for permission to reprint material.
A maximum of eight Tables may be included. Tables containing important backup data too extensive to be published may be made available online only as TRANSFUSION supplementary material. In that event, an appropriate statement will be added to the text.
FIGURES
Include a maximum of eight Figures. The best figures can be understood without having to refer to the Figure Legend or text. There are three preferred formats for digital artwork submission: Encapsulated PostScript (EPS), Portable Document Format (PDF) and Tagged Image Format (TIFF). We suggest that line art be saved as EPS files. Alternately, these may be saved as PDF files at 600 dots per inch (dpi) or better at final size. Tone art, or photographic images, should be saved as TIFF files with a resolution of 300 dpi at final size. For combination figures, or artwork that contains both photographs and labeling, we recommend saving them as EPS files, or as PDF files with a resolution of 600 dpi or better at final size. More detailed information on the submission of electronic artwork can be found here.
Photomicrographs must have internal scale markers, and the magnification must be stated. Symbols, arrows, or letters used in the photomicrographs should contrast with the background.
If any person is identifiable in a photograph, written permission from the subject(s) to use the photograph must accompany the manuscript. Cite each figure in the text in consecutive order. If a figure has been published, acknowledge the original source and submit with the manuscript written permission from the copyright holder (usually the publisher or journal) to reproduce the material. Permission is required, even for one's own publications, except for documents in the public domain.
FIGURE LEGENDS
Titles for illustrations belong in your Figure Legends on a separate page, not on the illustrations themselves. Label each figure clearly using Arabic numerals (FIGURE 1, FIGURE 2, etc.). When symbols, arrows, numbers, or letters are used to identify parts of illustrations, identify and explain each one in the legends. Explain internal scales and identify methods of preparation and staining of material that are illustrated in photomicrographs.
Photographs in color are published at the authors’ expense. Color reproduction in print is $700 per figure and is confirmed by the corresponding author during the production process.
ABBREVIATIONS
No abbreviations should be used in the title of the manuscript. The full term for which an abbreviation stands must precede its first use in the text for ALL abbreviations with the exception of units of measurement. Consult the following sources for additional standard abbreviations: 1) CSE Style Manual Committee. Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers. 7th ed. June 2006. 2) O'Conner M, Woodford FP. Writing scientific papers in English: an ELSE-Ciba foundation guide for authors. Amsterdam, Oxford, New York: elsevier-Excerpta Medica,1975; and 3) Day RA, Gaster B (2006) How to Write and Publish a Scientific Paper (6th Edition). Cambridge University Press, Cambridge.
BLOOD GROUP TERMINOLOGY
Please contact Connie Westhoff, PhD (cwesthoff@NYBloodcenter.org) with questions.
Red cell blood group antigen and allele terminology must follow the conventions and style according to the International Society of Blood Transfusion (ISBT) available on the ISBT Working Party on Red Cell Immunogenetics and Terminology website. Nomenclature of platelet-specific antigens should follow the conventions outlined in Metcalfe P et. al Vox Sang. 2003;85:240-245.
Units of Measurement
Measurements of length, height, weight, and volume should be reported in metric units (meter [m], kilogram [kg], liter [L]) or their decimal multiples. However, body weight may be reported in either kilograms (kg) or pounds (lb). Temperatures should be given in degrees Celsius. Blood pressure can be given in either torr or mmHg.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/15372995/homepage/forauthors.html
期刊编辑邮箱、电话【官网信息】
Editorial Board
Editor
Richard Kaufman, MD
Brigham and Women's Hospital
Blood Bank, Amory 260
75 Francis Street
rmkaufman@bwh.harvard.edu
Editorial Office
Betsy Ring
Brigham and Women's Hospital
Blood Bank, Amory 260
75 Francis Street
207-671-8233
bring1@bwh.harvard.edu
Associate Editors
Jason Acker, MBA, PhD
Canadian Blood Services
University of Alberta
8249 114 Street
Edmonton, AB T6G 2R8
780-702-8629
jason.acker@blood.ca
Donald M. Arnold, MD
McMaster University
1200 Main Street W
HSC-3V48
Hamilton, Ontario L8N3Z5
905-525-9140 ext. 21248
arnold@mcmaster.ca
Jose A. Cancelas, MD, PhD
University of Cincinnati Pediatrics
Hoxworth Blood Center
Clifton Avenue
Cincinnati, OH 45221
513-558-1324
jose.cancelas@uc.edu
Andrew P. Cap, MS, MD, PhD, FACP
US Army Institute of Surgical Research
3650 Chambers Pass
JBSA - Fort Sam Houston, TX 78234
210-323-6908
Andrew.p.cap.mil@mail.mil
Melissa Cushing, MD
New York Presbyterian Hospital/Weill Cornell Medicine
525 East 68th St.
New York, NY 10065
212-746-3527
Mec2013@med.cornell.edu
Anne F. Eder, MD, PhD
U. S. Food and Drug Administration
Center for Biologics Evaluation and Research
10903 New Hampshire Avenue
Silver Spring, MD 20903
240-402-8398
Anne.Eder.Transfusion@gmail.com
Willy Flegel, MD
National Institutes of Health
Building 10; Room 1C711
Bethesda, MD 20891
301-496-4506
flegelwa@cc.nih.gov
John R. Hess, MD, MPH
The University of Washington
Department of Laboratory Medicine
Seattle, WA 9819
206-744-3145
Hessj3@uw.edu
Cassandra D. Josephson, MD
Emory University
Pathology and Laboratory Medicine
1405 Clifton Rd. NE
Atlanta, GA 30322
770-378-6938
cjoseph@emory.edu
Dr. Zoe McQuilten, MBBS, PhD, FRACP, FRCPA
Australian Red Cross Blood Service
Transfusion Medicine Services
PO Box 354, South Melbourne
Melbourne
Victoria, Australia 3205
61 3 96940104
zoe.mcquilten@monash.edu
Jay E. Menitove, MD
637 W. 57th Terrace
Kansas City, MO 64113
816-651-6853
jmenitove@gmail.com
Beth H. Shaz, MD
Duke University School of Medicine
2400 Pratt Street, Suite 9011
Durham, NC 27710
919-668-4828
beth.shaz@duke.edu
Steven R. Sloan, MD, PhD
Boston Children's Hospital
Blood Bank
300 Longwood Ave., Bader 406
Boston, MA 02115
617-355-6268
steven.sloan@childrens.harvard.edu
Edward L. Snyder, MD
Yale-New Haven Hospital
Blood Bank Room CB-459
20 York Street
New Haven, CT 06504
203-688-2441
edward.snyder@yale.edu
Susan L. Stramer, Ph.D
American Red Cross
9315 Gaither Road
Gaithersburg, MD 20877
301-343-8249
Susan.Stramer@redcross.org
Lynne Uhl, MD
Beth Israel Deaconess Medical Center
Harvard Medical School
YA-309
330 Brookline Avenue
Boston, MA 02215
617-667-3648
luhl@bidmc.harvard.edu
Jonathan H. Waters, MD
University of Pittsburgh Medical Center
Magee Women’s Hospital
300 Halket Street
Pittsburgh, PA 15213
412-641-4260
watejh@upmc.edu
Connie Westhoff, PhD
New York Blood Center
310 East 67th St.
Manhattan, NY 10065
718-752-4670
cwesthoff@nybloodcenter.org
